nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—Choline—Carbachol—glaucoma	0.445	0.635	CrCrCtD
L-Carnitine—Bethanechol—Carbachol—glaucoma	0.255	0.365	CrCrCtD
L-Carnitine—SLC22A4—Clonidine—glaucoma	0.0753	0.639	CbGbCtD
L-Carnitine—SLC22A5—Clonidine—glaucoma	0.0426	0.361	CbGbCtD
L-Carnitine—SLC22A8—optic choroid—glaucoma	0.00176	0.178	CbGeAlD
L-Carnitine—SLC25A20—connective tissue—glaucoma	0.00115	0.117	CbGeAlD
L-Carnitine—CPT1A—Circadian rythm related genes—ATOH7—glaucoma	0.00114	0.0278	CbGpPWpGaD
L-Carnitine—SLC22A16—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.00108	0.0264	CbGpPWpGaD
L-Carnitine—CPT1A—eye—glaucoma	0.000939	0.0955	CbGeAlD
L-Carnitine—CPT1A—connective tissue—glaucoma	0.000905	0.092	CbGeAlD
L-Carnitine—MPO—endothelium—glaucoma	0.000901	0.0916	CbGeAlD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.000898	0.022	CbGpPWpGaD
L-Carnitine—CPT2—eye—glaucoma	0.000891	0.0906	CbGeAlD
L-Carnitine—CPT2—retina—glaucoma	0.000883	0.0898	CbGeAlD
L-Carnitine—CPT2—connective tissue—glaucoma	0.000859	0.0873	CbGeAlD
L-Carnitine—SLC22A16—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000791	0.0193	CbGpPWpGaD
L-Carnitine—CPT1A—AMPK Signaling—RPTOR—glaucoma	0.000751	0.0184	CbGpPWpGaD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000736	0.018	CbGpPWpGaD
L-Carnitine—XDH—Effects of Nitric Oxide—NOS3—glaucoma	0.000722	0.0177	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—CA1—glaucoma	0.000642	0.0157	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—PEX19—glaucoma	0.000554	0.0135	CbGpPWpGaD
L-Carnitine—CES1—connective tissue—glaucoma	0.00051	0.0518	CbGeAlD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000491	0.012	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000467	0.0114	CbGpPWpGaD
L-Carnitine—XDH—Oxidative Stress—SOD1—glaucoma	0.000454	0.0111	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—OPN4—glaucoma	0.000453	0.0111	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CA5A—glaucoma	0.00044	0.0108	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—NARFL—glaucoma	0.00044	0.0108	CbGpPWpGaD
L-Carnitine—MPO—connective tissue—glaucoma	0.000426	0.0433	CbGeAlD
L-Carnitine—CPT1A—FOXA2 and FOXA3 transcription factor networks—NR3C1—glaucoma	0.000418	0.0102	CbGpPWpGaD
L-Carnitine—SLC25A20—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	0.00041	0.01	CbGpPWpGaD
L-Carnitine—CES1—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00041	0.01	CbGpPWpGaD
L-Carnitine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.0004	0.00978	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—TXN—glaucoma	0.000398	0.00974	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000397	0.00972	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000397	0.00972	CbGpPWpGaD
L-Carnitine—CPT2—PPARA activates gene expression—ABCA1—glaucoma	0.000392	0.00959	CbGpPWpGaD
L-Carnitine—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	0.000384	0.00938	CbGpPWpGaD
L-Carnitine—XDH—Nucleotide metabolism—TXN—glaucoma	0.000383	0.00938	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—ABCA1—glaucoma	0.000381	0.00931	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CA5A—glaucoma	0.000374	0.00915	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—NARFL—glaucoma	0.000374	0.00915	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—NARFL—glaucoma	0.000374	0.00915	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CA5A—glaucoma	0.000374	0.00915	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000374	0.00915	CbGpPWpGaD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000359	0.00879	CbGpPWpGaD
L-Carnitine—SLC22A8—eye—glaucoma	0.000353	0.0359	CbGeAlD
L-Carnitine—CPT1A—Circadian Clock—NR3C1—glaucoma	0.00035	0.00856	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—TXN—glaucoma	0.000348	0.00852	CbGpPWpGaD
L-Carnitine—CES1—NRF2 pathway—SLC6A13—glaucoma	0.000348	0.00851	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—SOD1—glaucoma	0.000339	0.0083	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000322	0.00788	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—ABCA1—glaucoma	0.00031	0.00758	CbGpPWpGaD
L-Carnitine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000301	0.00735	CbGpPWpGaD
L-Carnitine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000293	0.00716	CbGpPWpGaD
L-Carnitine—CES1—NRF2 pathway—TXN—glaucoma	0.000286	0.00699	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—SOD1—glaucoma	0.000276	0.00675	CbGpPWpGaD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000272	0.00666	CbGpPWpGaD
L-Carnitine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000272	0.00665	CbGpPWpGaD
L-Carnitine—CPT1A—PPARA activates gene expression—ABCA1—glaucoma	0.000272	0.00665	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—MTHFR—glaucoma	0.000269	0.00658	CbGpPWpGaD
L-Carnitine—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	0.000266	0.0065	CbGpPWpGaD
L-Carnitine—SLC22A5—retina—glaucoma	0.000265	0.0269	CbGeAlD
L-Carnitine—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	0.000264	0.00647	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000256	0.00626	CbGpPWpGaD
L-Carnitine—CES1—NRF2 pathway—SLC6A1—glaucoma	0.000255	0.00623	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—APOE—glaucoma	0.00025	0.00613	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00025	0.0061	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—ABCA1—glaucoma	0.000246	0.00602	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CA5A—glaucoma	0.000241	0.0059	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—NARFL—glaucoma	0.000241	0.0059	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.00023	0.00564	CbGpPWpGaD
L-Carnitine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.00022	0.00538	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—SOD1—glaucoma	0.000219	0.00537	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—MTHFR—glaucoma	0.000219	0.00535	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—ABCA1—glaucoma	0.000215	0.00526	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CA1—glaucoma	0.000215	0.00526	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CTSA—glaucoma	0.000208	0.00509	CbGpPWpGaD
L-Carnitine—CES1—NRF2 pathway—TGFB2—glaucoma	0.000208	0.00508	CbGpPWpGaD
L-Carnitine—Myalgia—Pilocarpine—glaucoma	0.000206	0.00157	CcSEcCtD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—PEX19—glaucoma	0.000205	0.00501	CbGpPWpGaD
L-Carnitine—Anxiety—Pilocarpine—glaucoma	0.000205	0.00156	CcSEcCtD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000205	0.00501	CbGpPWpGaD
L-Carnitine—Paraesthesia—Acetazolamide—glaucoma	0.000204	0.00156	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—GSTM1—glaucoma	0.000204	0.005	CbGpPWpGaD
L-Carnitine—Hypotension—Brimonidine—glaucoma	0.000204	0.00156	CcSEcCtD
L-Carnitine—Nausea—Levobunolol—glaucoma	0.000204	0.00156	CcSEcCtD
L-Carnitine—Infection—Brinzolamide—glaucoma	0.000204	0.00155	CcSEcCtD
L-Carnitine—Tachycardia—Travoprost—glaucoma	0.000203	0.00155	CcSEcCtD
L-Carnitine—Sinusitis—Betaxolol—glaucoma	0.000202	0.00154	CcSEcCtD
L-Carnitine—Abdominal pain—Apraclonidine—glaucoma	0.000201	0.00153	CcSEcCtD
L-Carnitine—Angiopathy—Clonidine—glaucoma	0.000201	0.00153	CcSEcCtD
L-Carnitine—Rash—Latanoprost—glaucoma	0.000201	0.00153	CcSEcCtD
L-Carnitine—Dermatitis—Latanoprost—glaucoma	0.0002	0.00153	CcSEcCtD
L-Carnitine—Dyspepsia—Acetazolamide—glaucoma	0.0002	0.00153	CcSEcCtD
L-Carnitine—Tachycardia—Brinzolamide—glaucoma	0.0002	0.00153	CcSEcCtD
L-Carnitine—Headache—Latanoprost—glaucoma	0.000199	0.00152	CcSEcCtD
L-Carnitine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000199	0.00487	CbGpPWpGaD
L-Carnitine—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000199	0.00152	CcSEcCtD
L-Carnitine—Anorexia—Dorzolamide—glaucoma	0.000199	0.00152	CcSEcCtD
L-Carnitine—Arrhythmia—Clonidine—glaucoma	0.000198	0.00151	CcSEcCtD
L-Carnitine—Decreased appetite—Acetazolamide—glaucoma	0.000198	0.00151	CcSEcCtD
L-Carnitine—Insomnia—Brimonidine—glaucoma	0.000197	0.00151	CcSEcCtD
L-Carnitine—CROT—Metabolism—CA2—glaucoma	0.000197	0.00481	CbGpPWpGaD
L-Carnitine—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000196	0.0015	CcSEcCtD
L-Carnitine—Paraesthesia—Brimonidine—glaucoma	0.000196	0.0015	CcSEcCtD
L-Carnitine—Infection—Pilocarpine—glaucoma	0.000196	0.00149	CcSEcCtD
L-Carnitine—Nausea—Methazolamide—glaucoma	0.000195	0.00149	CcSEcCtD
L-Carnitine—Hypotension—Dorzolamide—glaucoma	0.000195	0.00149	CcSEcCtD
L-Carnitine—Dyspnoea—Brimonidine—glaucoma	0.000195	0.00149	CcSEcCtD
L-Carnitine—Hypotension—Travoprost—glaucoma	0.000194	0.00148	CcSEcCtD
L-Carnitine—Rhinitis—Betaxolol—glaucoma	0.000193	0.00148	CcSEcCtD
L-Carnitine—Tachycardia—Pilocarpine—glaucoma	0.000192	0.00147	CcSEcCtD
L-Carnitine—Dyspepsia—Brimonidine—glaucoma	0.000192	0.00147	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000192	0.0047	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000192	0.0047	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—SOD1—glaucoma	0.000192	0.00469	CbGpPWpGaD
L-Carnitine—Hypotension—Brinzolamide—glaucoma	0.000192	0.00146	CcSEcCtD
L-Carnitine—Pharyngitis—Betaxolol—glaucoma	0.000191	0.00146	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.00019	0.00145	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Travoprost—glaucoma	0.000189	0.00144	CcSEcCtD
L-Carnitine—Insomnia—Dorzolamide—glaucoma	0.000189	0.00144	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Brimonidine—glaucoma	0.000189	0.00144	CcSEcCtD
L-Carnitine—Anorexia—Pilocarpine—glaucoma	0.000188	0.00143	CcSEcCtD
L-Carnitine—Hypersensitivity—Apraclonidine—glaucoma	0.000187	0.00143	CcSEcCtD
L-Carnitine—Paraesthesia—Dorzolamide—glaucoma	0.000187	0.00143	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000187	0.00143	CcSEcCtD
L-Carnitine—Pain—Brimonidine—glaucoma	0.000187	0.00142	CcSEcCtD
L-Carnitine—Dyspnoea—Dorzolamide—glaucoma	0.000186	0.00142	CcSEcCtD
L-Carnitine—Insomnia—Brinzolamide—glaucoma	0.000185	0.00142	CcSEcCtD
L-Carnitine—Muscle spasms—Clonidine—glaucoma	0.000185	0.00141	CcSEcCtD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000185	0.00453	CbGpPWpGaD
L-Carnitine—Dyspnoea—Travoprost—glaucoma	0.000185	0.00141	CcSEcCtD
L-Carnitine—Hypotension—Pilocarpine—glaucoma	0.000184	0.00141	CcSEcCtD
L-Carnitine—Paraesthesia—Brinzolamide—glaucoma	0.000184	0.0014	CcSEcCtD
L-Carnitine—Dyspepsia—Dorzolamide—glaucoma	0.000184	0.0014	CcSEcCtD
L-Carnitine—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	0.000183	0.00448	CbGpPWpGaD
L-Carnitine—Dyspnoea—Brinzolamide—glaucoma	0.000183	0.00139	CcSEcCtD
L-Carnitine—Dyspepsia—Travoprost—glaucoma	0.000183	0.00139	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—CA1—glaucoma	0.000183	0.00447	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CA1—glaucoma	0.000183	0.00447	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000183	0.00447	CbGpPWpGaD
L-Carnitine—Asthenia—Apraclonidine—glaucoma	0.000182	0.00139	CcSEcCtD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000182	0.00445	CbGpPWpGaD
L-Carnitine—Decreased appetite—Dorzolamide—glaucoma	0.000181	0.00138	CcSEcCtD
L-Carnitine—Dyspepsia—Brinzolamide—glaucoma	0.00018	0.00138	CcSEcCtD
L-Carnitine—Eye disorder—Betaxolol—glaucoma	0.00018	0.00138	CcSEcCtD
L-Carnitine—Pruritus—Apraclonidine—glaucoma	0.00018	0.00137	CcSEcCtD
L-Carnitine—Body temperature increased—Acetazolamide—glaucoma	0.00018	0.00137	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.00018	0.00137	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Travoprost—glaucoma	0.000179	0.00137	CcSEcCtD
L-Carnitine—Pain—Dorzolamide—glaucoma	0.000178	0.00136	CcSEcCtD
L-Carnitine—Insomnia—Pilocarpine—glaucoma	0.000178	0.00136	CcSEcCtD
L-Carnitine—Decreased appetite—Brinzolamide—glaucoma	0.000178	0.00136	CcSEcCtD
L-Carnitine—Weight decreased—Timolol—glaucoma	0.000178	0.00136	CcSEcCtD
L-Carnitine—Pain—Travoprost—glaucoma	0.000178	0.00135	CcSEcCtD
L-Carnitine—Constipation—Travoprost—glaucoma	0.000178	0.00135	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000177	0.00434	CbGpPWpGaD
L-Carnitine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000177	0.00135	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—CTSA—glaucoma	0.000177	0.00433	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CTSA—glaucoma	0.000177	0.00433	CbGpPWpGaD
L-Carnitine—Paraesthesia—Pilocarpine—glaucoma	0.000177	0.00135	CcSEcCtD
L-Carnitine—Asthenia—Bimatoprost—glaucoma	0.000177	0.00135	CcSEcCtD
L-Carnitine—Dyspnoea—Pilocarpine—glaucoma	0.000176	0.00134	CcSEcCtD
L-Carnitine—Pain—Brinzolamide—glaucoma	0.000175	0.00134	CcSEcCtD
L-Carnitine—Depression—Timolol—glaucoma	0.000175	0.00134	CcSEcCtD
L-Carnitine—Angiopathy—Betaxolol—glaucoma	0.000175	0.00134	CcSEcCtD
L-Carnitine—Pruritus—Bimatoprost—glaucoma	0.000174	0.00133	CcSEcCtD
L-Carnitine—Diarrhoea—Apraclonidine—glaucoma	0.000174	0.00133	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—MTHFR—glaucoma	0.000174	0.00425	CbGpPWpGaD
L-Carnitine—Dyspepsia—Pilocarpine—glaucoma	0.000173	0.00132	CcSEcCtD
L-Carnitine—Arrhythmia—Betaxolol—glaucoma	0.000172	0.00131	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000172	0.00421	CbGpPWpGaD
L-Carnitine—Decreased appetite—Pilocarpine—glaucoma	0.000171	0.00131	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Dorzolamide—glaucoma	0.000171	0.0013	CcSEcCtD
L-Carnitine—Palpitations—Clonidine—glaucoma	0.00017	0.0013	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00017	0.0013	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Travoprost—glaucoma	0.00017	0.0013	CcSEcCtD
L-Carnitine—Pain—Pilocarpine—glaucoma	0.000168	0.00129	CcSEcCtD
L-Carnitine—Constipation—Pilocarpine—glaucoma	0.000168	0.00129	CcSEcCtD
L-Carnitine—Cough—Clonidine—glaucoma	0.000168	0.00128	CcSEcCtD
L-Carnitine—Dizziness—Apraclonidine—glaucoma	0.000168	0.00128	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—CA2—glaucoma	0.000167	0.00409	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NARFL—glaucoma	0.000167	0.00409	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CA5A—glaucoma	0.000167	0.00409	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CA2—glaucoma	0.000167	0.00409	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000165	0.00404	CbGpPWpGaD
L-Carnitine—Body temperature increased—Dorzolamide—glaucoma	0.000165	0.00126	CcSEcCtD
L-Carnitine—Abdominal pain—Dorzolamide—glaucoma	0.000165	0.00126	CcSEcCtD
L-Carnitine—Sinusitis—Timolol—glaucoma	0.000165	0.00126	CcSEcCtD
L-Carnitine—Dysgeusia—Betaxolol—glaucoma	0.000164	0.00125	CcSEcCtD
L-Carnitine—Chest pain—Clonidine—glaucoma	0.000164	0.00125	CcSEcCtD
L-Carnitine—Abdominal pain—Travoprost—glaucoma	0.000164	0.00125	CcSEcCtD
L-Carnitine—Anxiety—Clonidine—glaucoma	0.000164	0.00125	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000163	0.004	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000163	0.004	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000163	0.004	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000163	0.004	CbGpPWpGaD
L-Carnitine—Asthenia—Acetazolamide—glaucoma	0.000163	0.00125	CcSEcCtD
L-Carnitine—Dizziness—Bimatoprost—glaucoma	0.000163	0.00124	CcSEcCtD
L-Carnitine—Vomiting—Apraclonidine—glaucoma	0.000162	0.00123	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—NGFR—glaucoma	0.000161	0.00395	CbGpPWpGaD
L-Carnitine—Muscle spasms—Betaxolol—glaucoma	0.000161	0.00123	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000161	0.00123	CcSEcCtD
L-Carnitine—Hypersensitivity—Brimonidine—glaucoma	0.000161	0.00123	CcSEcCtD
L-Carnitine—Dermatitis—Apraclonidine—glaucoma	0.00016	0.00122	CcSEcCtD
L-Carnitine—Headache—Apraclonidine—glaucoma	0.000159	0.00122	CcSEcCtD
L-Carnitine—Rhinitis—Timolol—glaucoma	0.000158	0.00121	CcSEcCtD
L-Carnitine—Asthenia—Brimonidine—glaucoma	0.000157	0.0012	CcSEcCtD
L-Carnitine—Infection—Clonidine—glaucoma	0.000156	0.00119	CcSEcCtD
L-Carnitine—Abdominal pain—Pilocarpine—glaucoma	0.000156	0.00119	CcSEcCtD
L-Carnitine—Body temperature increased—Pilocarpine—glaucoma	0.000156	0.00119	CcSEcCtD
L-Carnitine—Diarrhoea—Acetazolamide—glaucoma	0.000156	0.00119	CcSEcCtD
L-Carnitine—CES1—Fluoropyrimidine Activity—TP53—glaucoma	0.000156	0.00381	CbGpPWpGaD
L-Carnitine—Rash—Bimatoprost—glaucoma	0.000155	0.00119	CcSEcCtD
L-Carnitine—Dermatitis—Bimatoprost—glaucoma	0.000155	0.00119	CcSEcCtD
L-Carnitine—Oedema peripheral—Timolol—glaucoma	0.000155	0.00118	CcSEcCtD
L-Carnitine—Anaemia—Betaxolol—glaucoma	0.000155	0.00118	CcSEcCtD
L-Carnitine—Pruritus—Brimonidine—glaucoma	0.000154	0.00118	CcSEcCtD
L-Carnitine—Headache—Bimatoprost—glaucoma	0.000154	0.00118	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—PEX19—glaucoma	0.000154	0.00377	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Dorzolamide—glaucoma	0.000154	0.00117	CcSEcCtD
L-Carnitine—Tachycardia—Clonidine—glaucoma	0.000154	0.00117	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—NTRK1—glaucoma	0.000153	0.00375	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Travoprost—glaucoma	0.000153	0.00117	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—NGF—glaucoma	0.000153	0.00373	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—MTHFR—glaucoma	0.000152	0.00372	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000152	0.00372	CbGpPWpGaD
L-Carnitine—Nausea—Apraclonidine—glaucoma	0.000151	0.00115	CcSEcCtD
L-Carnitine—Hypersensitivity—Brinzolamide—glaucoma	0.000151	0.00115	CcSEcCtD
L-Carnitine—Vertigo—Betaxolol—glaucoma	0.000151	0.00115	CcSEcCtD
L-Carnitine—Dizziness—Acetazolamide—glaucoma	0.00015	0.00115	CcSEcCtD
L-Carnitine—Anorexia—Clonidine—glaucoma	0.00015	0.00114	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—TNF—glaucoma	0.00015	0.00366	CbGpPWpGaD
L-Carnitine—Asthenia—Dorzolamide—glaucoma	0.00015	0.00114	CcSEcCtD
L-Carnitine—Asthenia—Travoprost—glaucoma	0.000149	0.00114	CcSEcCtD
L-Carnitine—Palpitations—Betaxolol—glaucoma	0.000148	0.00113	CcSEcCtD
L-Carnitine—CES1—E2F transcription factor network—CDKN2A—glaucoma	0.000148	0.00362	CbGpPWpGaD
L-Carnitine—Pruritus—Dorzolamide—glaucoma	0.000148	0.00113	CcSEcCtD
L-Carnitine—Eye disorder—Timolol—glaucoma	0.000147	0.00112	CcSEcCtD
L-Carnitine—Asthenia—Brinzolamide—glaucoma	0.000147	0.00112	CcSEcCtD
L-Carnitine—Hypotension—Clonidine—glaucoma	0.000147	0.00112	CcSEcCtD
L-Carnitine—Pruritus—Travoprost—glaucoma	0.000147	0.00112	CcSEcCtD
L-Carnitine—Cough—Betaxolol—glaucoma	0.000146	0.00112	CcSEcCtD
L-Carnitine—Nausea—Bimatoprost—glaucoma	0.000146	0.00112	CcSEcCtD
L-Carnitine—Hypersensitivity—Pilocarpine—glaucoma	0.000145	0.00111	CcSEcCtD
L-Carnitine—Pruritus—Brinzolamide—glaucoma	0.000145	0.00111	CcSEcCtD
L-Carnitine—Vomiting—Acetazolamide—glaucoma	0.000145	0.0011	CcSEcCtD
L-Carnitine—Dizziness—Brimonidine—glaucoma	0.000144	0.0011	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Clonidine—glaucoma	0.000143	0.00109	CcSEcCtD
L-Carnitine—Angiopathy—Timolol—glaucoma	0.000143	0.00109	CcSEcCtD
L-Carnitine—Chest pain—Betaxolol—glaucoma	0.000143	0.00109	CcSEcCtD
L-Carnitine—Myalgia—Betaxolol—glaucoma	0.000143	0.00109	CcSEcCtD
L-Carnitine—Diarrhoea—Dorzolamide—glaucoma	0.000143	0.00109	CcSEcCtD
L-Carnitine—Headache—Acetazolamide—glaucoma	0.000143	0.00109	CcSEcCtD
L-Carnitine—Anxiety—Betaxolol—glaucoma	0.000142	0.00109	CcSEcCtD
L-Carnitine—Insomnia—Clonidine—glaucoma	0.000142	0.00109	CcSEcCtD
L-Carnitine—Diarrhoea—Travoprost—glaucoma	0.000142	0.00108	CcSEcCtD
L-Carnitine—Asthenia—Pilocarpine—glaucoma	0.000141	0.00108	CcSEcCtD
L-Carnitine—Paraesthesia—Clonidine—glaucoma	0.000141	0.00108	CcSEcCtD
L-Carnitine—CES1—NRF2 pathway—GSTM1—glaucoma	0.000141	0.00345	CbGpPWpGaD
L-Carnitine—Arrhythmia—Timolol—glaucoma	0.000141	0.00107	CcSEcCtD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000141	0.00344	CbGpPWpGaD
L-Carnitine—Dyspnoea—Clonidine—glaucoma	0.00014	0.00107	CcSEcCtD
L-Carnitine—Diarrhoea—Brinzolamide—glaucoma	0.00014	0.00107	CcSEcCtD
L-Carnitine—Pruritus—Pilocarpine—glaucoma	0.000139	0.00106	CcSEcCtD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—PEX19—glaucoma	0.000139	0.00341	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—TXN—glaucoma	0.000138	0.00339	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000138	0.00339	CbGpPWpGaD
L-Carnitine—Dizziness—Dorzolamide—glaucoma	0.000138	0.00105	CcSEcCtD
L-Carnitine—Rash—Brimonidine—glaucoma	0.000138	0.00105	CcSEcCtD
L-Carnitine—Dermatitis—Brimonidine—glaucoma	0.000138	0.00105	CcSEcCtD
L-Carnitine—Dizziness—Travoprost—glaucoma	0.000137	0.00105	CcSEcCtD
L-Carnitine—Headache—Brimonidine—glaucoma	0.000137	0.00104	CcSEcCtD
L-Carnitine—Decreased appetite—Clonidine—glaucoma	0.000137	0.00104	CcSEcCtD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000137	0.00334	CbGpPWpGaD
L-Carnitine—Infection—Betaxolol—glaucoma	0.000136	0.00104	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Clonidine—glaucoma	0.000136	0.00104	CcSEcCtD
L-Carnitine—Dizziness—Brinzolamide—glaucoma	0.000136	0.00103	CcSEcCtD
L-Carnitine—Nausea—Acetazolamide—glaucoma	0.000135	0.00103	CcSEcCtD
L-Carnitine—Diarrhoea—Pilocarpine—glaucoma	0.000135	0.00103	CcSEcCtD
L-Carnitine—Constipation—Clonidine—glaucoma	0.000135	0.00103	CcSEcCtD
L-Carnitine—Pain—Clonidine—glaucoma	0.000135	0.00103	CcSEcCtD
L-Carnitine—Dysgeusia—Timolol—glaucoma	0.000134	0.00102	CcSEcCtD
L-Carnitine—Tachycardia—Betaxolol—glaucoma	0.000134	0.00102	CcSEcCtD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000133	0.00325	CbGpPWpGaD
L-Carnitine—Vomiting—Dorzolamide—glaucoma	0.000133	0.00101	CcSEcCtD
L-Carnitine—Rash—Dorzolamide—glaucoma	0.000131	0.001	CcSEcCtD
L-Carnitine—Dermatitis—Dorzolamide—glaucoma	0.000131	0.001	CcSEcCtD
L-Carnitine—CES1—E2F transcription factor network—CDKN1B—glaucoma	0.000131	0.00321	CbGpPWpGaD
L-Carnitine—Rash—Travoprost—glaucoma	0.000131	0.000999	CcSEcCtD
L-Carnitine—Dermatitis—Travoprost—glaucoma	0.000131	0.000998	CcSEcCtD
L-Carnitine—Headache—Dorzolamide—glaucoma	0.000131	0.000997	CcSEcCtD
L-Carnitine—Anorexia—Betaxolol—glaucoma	0.000131	0.000997	CcSEcCtD
L-Carnitine—Vomiting—Brinzolamide—glaucoma	0.00013	0.000995	CcSEcCtD
L-Carnitine—Dizziness—Pilocarpine—glaucoma	0.00013	0.000994	CcSEcCtD
L-Carnitine—Headache—Travoprost—glaucoma	0.00013	0.000993	CcSEcCtD
L-Carnitine—Nausea—Brimonidine—glaucoma	0.00013	0.00099	CcSEcCtD
L-Carnitine—Rash—Brinzolamide—glaucoma	0.000129	0.000986	CcSEcCtD
L-Carnitine—Dermatitis—Brinzolamide—glaucoma	0.000129	0.000986	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Clonidine—glaucoma	0.000129	0.000982	CcSEcCtD
L-Carnitine—Headache—Brinzolamide—glaucoma	0.000128	0.00098	CcSEcCtD
L-Carnitine—Hypotension—Betaxolol—glaucoma	0.000128	0.000977	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000126	0.00309	CbGpPWpGaD
L-Carnitine—Vomiting—Pilocarpine—glaucoma	0.000125	0.000956	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000125	0.00306	CbGpPWpGaD
L-Carnitine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000125	0.000952	CcSEcCtD
L-Carnitine—Abdominal pain—Clonidine—glaucoma	0.000124	0.000949	CcSEcCtD
L-Carnitine—Body temperature increased—Clonidine—glaucoma	0.000124	0.000949	CcSEcCtD
L-Carnitine—Rash—Pilocarpine—glaucoma	0.000124	0.000948	CcSEcCtD
L-Carnitine—Dermatitis—Pilocarpine—glaucoma	0.000124	0.000947	CcSEcCtD
L-Carnitine—Insomnia—Betaxolol—glaucoma	0.000124	0.000946	CcSEcCtD
L-Carnitine—Nausea—Dorzolamide—glaucoma	0.000124	0.000945	CcSEcCtD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000124	0.00302	CbGpPWpGaD
L-Carnitine—Headache—Pilocarpine—glaucoma	0.000123	0.000942	CcSEcCtD
L-Carnitine—Nausea—Travoprost—glaucoma	0.000123	0.000941	CcSEcCtD
L-Carnitine—Vertigo—Timolol—glaucoma	0.000123	0.00094	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—CDKN2A—glaucoma	0.000123	0.00301	CbGpPWpGaD
L-Carnitine—Paraesthesia—Betaxolol—glaucoma	0.000123	0.000939	CcSEcCtD
L-Carnitine—Dyspnoea—Betaxolol—glaucoma	0.000122	0.000932	CcSEcCtD
L-Carnitine—Nausea—Brinzolamide—glaucoma	0.000122	0.000929	CcSEcCtD
L-Carnitine—Palpitations—Timolol—glaucoma	0.000121	0.000925	CcSEcCtD
L-Carnitine—Dyspepsia—Betaxolol—glaucoma	0.000121	0.00092	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—FAS—glaucoma	0.00012	0.00294	CbGpPWpGaD
L-Carnitine—Cough—Timolol—glaucoma	0.00012	0.000913	CcSEcCtD
L-Carnitine—Decreased appetite—Betaxolol—glaucoma	0.000119	0.000909	CcSEcCtD
L-Carnitine—Hypertension—Timolol—glaucoma	0.000118	0.000903	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000118	0.000903	CcSEcCtD
L-Carnitine—CPT2—Metabolism—CA1—glaucoma	0.000118	0.00288	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—TXN—glaucoma	0.000118	0.00288	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—TXN—glaucoma	0.000118	0.00288	CbGpPWpGaD
L-Carnitine—Constipation—Betaxolol—glaucoma	0.000117	0.000894	CcSEcCtD
L-Carnitine—Pain—Betaxolol—glaucoma	0.000117	0.000894	CcSEcCtD
L-Carnitine—Nausea—Pilocarpine—glaucoma	0.000117	0.000893	CcSEcCtD
L-Carnitine—Myalgia—Timolol—glaucoma	0.000117	0.000891	CcSEcCtD
L-Carnitine—Chest pain—Timolol—glaucoma	0.000117	0.000891	CcSEcCtD
L-Carnitine—Anxiety—Timolol—glaucoma	0.000116	0.000888	CcSEcCtD
L-Carnitine—Hypersensitivity—Clonidine—glaucoma	0.000116	0.000885	CcSEcCtD
L-Carnitine—MPO—Vitamin B12 Metabolism—TNF—glaucoma	0.000116	0.00283	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—PTGS2—glaucoma	0.000115	0.00282	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CTSA—glaucoma	0.000114	0.00279	CbGpPWpGaD
L-Carnitine—Asthenia—Clonidine—glaucoma	0.000113	0.000862	CcSEcCtD
L-Carnitine—Pruritus—Clonidine—glaucoma	0.000111	0.00085	CcSEcCtD
L-Carnitine—Infection—Timolol—glaucoma	0.000111	0.000848	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—PTGS2—glaucoma	0.000111	0.00271	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NARFL—glaucoma	0.000111	0.00271	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CA5A—glaucoma	0.000111	0.00271	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—CDKN1B—glaucoma	0.000109	0.00267	CbGpPWpGaD
L-Carnitine—Body temperature increased—Betaxolol—glaucoma	0.000108	0.000826	CcSEcCtD
L-Carnitine—CPT2—Metabolism—CA2—glaucoma	0.000108	0.00263	CbGpPWpGaD
L-Carnitine—Diarrhoea—Clonidine—glaucoma	0.000108	0.000822	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000107	0.00263	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000107	0.00263	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—GSTT1—glaucoma	0.000107	0.00263	CbGpPWpGaD
L-Carnitine—Anorexia—Timolol—glaucoma	0.000107	0.000814	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000106	0.0026	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000106	0.0026	CbGpPWpGaD
L-Carnitine—CPT1A—AMPK Signaling—TP53—glaucoma	0.000106	0.00259	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000106	0.00259	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000105	0.00257	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000105	0.00257	CbGpPWpGaD
L-Carnitine—Hypotension—Timolol—glaucoma	0.000105	0.000798	CcSEcCtD
L-Carnitine—Dizziness—Clonidine—glaucoma	0.000104	0.000794	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000104	0.00255	CbGpPWpGaD
L-Carnitine—Musculoskeletal discomfort—Timolol—glaucoma	0.000102	0.000778	CcSEcCtD
L-Carnitine—Insomnia—Timolol—glaucoma	0.000101	0.000772	CcSEcCtD
L-Carnitine—Hypersensitivity—Betaxolol—glaucoma	0.000101	0.00077	CcSEcCtD
L-Carnitine—Paraesthesia—Timolol—glaucoma	0.0001	0.000767	CcSEcCtD
L-Carnitine—Vomiting—Clonidine—glaucoma	0.0001	0.000763	CcSEcCtD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.0001	0.00245	CbGpPWpGaD
L-Carnitine—Dyspnoea—Timolol—glaucoma	9.98e-05	0.000761	CcSEcCtD
L-Carnitine—Rash—Clonidine—glaucoma	9.92e-05	0.000757	CcSEcCtD
L-Carnitine—Dermatitis—Clonidine—glaucoma	9.91e-05	0.000756	CcSEcCtD
L-Carnitine—Headache—Clonidine—glaucoma	9.86e-05	0.000752	CcSEcCtD
L-Carnitine—Dyspepsia—Timolol—glaucoma	9.85e-05	0.000752	CcSEcCtD
L-Carnitine—Asthenia—Betaxolol—glaucoma	9.83e-05	0.00075	CcSEcCtD
L-Carnitine—Decreased appetite—Timolol—glaucoma	9.73e-05	0.000742	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—PTGS2—glaucoma	9.7e-05	0.00237	CbGpPWpGaD
L-Carnitine—Pruritus—Betaxolol—glaucoma	9.69e-05	0.00074	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Timolol—glaucoma	9.66e-05	0.000737	CcSEcCtD
L-Carnitine—Pain—Timolol—glaucoma	9.57e-05	0.00073	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—TNF—glaucoma	9.43e-05	0.00231	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC4A4—glaucoma	9.41e-05	0.0023	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	9.38e-05	0.00229	CbGpPWpGaD
L-Carnitine—Diarrhoea—Betaxolol—glaucoma	9.37e-05	0.000715	CcSEcCtD
L-Carnitine—Nausea—Clonidine—glaucoma	9.35e-05	0.000713	CcSEcCtD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC6A13—glaucoma	9.24e-05	0.00226	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Timolol—glaucoma	9.15e-05	0.000698	CcSEcCtD
L-Carnitine—CRAT—Metabolism—GSTT1—glaucoma	9.13e-05	0.00223	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GSTT1—glaucoma	9.13e-05	0.00223	CbGpPWpGaD
L-Carnitine—Dizziness—Betaxolol—glaucoma	9.06e-05	0.000691	CcSEcCtD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC6A1—glaucoma	9.04e-05	0.00221	CbGpPWpGaD
L-Carnitine—Body temperature increased—Timolol—glaucoma	8.85e-05	0.000675	CcSEcCtD
L-Carnitine—Abdominal pain—Timolol—glaucoma	8.85e-05	0.000675	CcSEcCtD
L-Carnitine—Vomiting—Betaxolol—glaucoma	8.71e-05	0.000665	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.66e-05	0.00212	CbGpPWpGaD
L-Carnitine—Rash—Betaxolol—glaucoma	8.64e-05	0.000659	CcSEcCtD
L-Carnitine—Dermatitis—Betaxolol—glaucoma	8.63e-05	0.000659	CcSEcCtD
L-Carnitine—Headache—Betaxolol—glaucoma	8.58e-05	0.000655	CcSEcCtD
L-Carnitine—CROT—Metabolism—ABCA1—glaucoma	8.55e-05	0.00209	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CYP1B1—glaucoma	8.55e-05	0.00209	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—TP53—glaucoma	8.31e-05	0.00203	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Timolol—glaucoma	8.25e-05	0.000629	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—CA1—glaucoma	8.16e-05	0.002	CbGpPWpGaD
L-Carnitine—Nausea—Betaxolol—glaucoma	8.14e-05	0.000621	CcSEcCtD
L-Carnitine—Asthenia—Timolol—glaucoma	8.03e-05	0.000613	CcSEcCtD
L-Carnitine—Pruritus—Timolol—glaucoma	7.92e-05	0.000604	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—CTSA—glaucoma	7.9e-05	0.00193	CbGpPWpGaD
L-Carnitine—Diarrhoea—Timolol—glaucoma	7.66e-05	0.000584	CcSEcCtD
L-Carnitine—CPT2—Metabolism—TXN—glaucoma	7.59e-05	0.00186	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—TNF—glaucoma	7.49e-05	0.00183	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CA2—glaucoma	7.46e-05	0.00183	CbGpPWpGaD
L-Carnitine—Dizziness—Timolol—glaucoma	7.4e-05	0.000565	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.36e-05	0.0018	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.36e-05	0.0018	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.3e-05	0.00178	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.3e-05	0.00178	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—VEGFA—glaucoma	7.29e-05	0.00178	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CYP1B1—glaucoma	7.27e-05	0.00178	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—ABCA1—glaucoma	7.27e-05	0.00178	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—ABCA1—glaucoma	7.27e-05	0.00178	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CYP1B1—glaucoma	7.27e-05	0.00178	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC4A4—glaucoma	7.14e-05	0.00175	CbGpPWpGaD
L-Carnitine—Vomiting—Timolol—glaucoma	7.12e-05	0.000543	CcSEcCtD
L-Carnitine—Rash—Timolol—glaucoma	7.06e-05	0.000538	CcSEcCtD
L-Carnitine—Dermatitis—Timolol—glaucoma	7.05e-05	0.000538	CcSEcCtD
L-Carnitine—Headache—Timolol—glaucoma	7.01e-05	0.000535	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC6A13—glaucoma	6.94e-05	0.0017	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—APOE—glaucoma	6.92e-05	0.00169	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	6.87e-05	0.00168	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	6.86e-05	0.00168	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—GSTM1—glaucoma	6.84e-05	0.00167	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC6A1—glaucoma	6.76e-05	0.00165	CbGpPWpGaD
L-Carnitine—Nausea—Timolol—glaucoma	6.65e-05	0.000507	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—TNF—glaucoma	6.55e-05	0.0016	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC6A13—glaucoma	6.28e-05	0.00154	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—TNF—glaucoma	6.25e-05	0.00153	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.19e-05	0.00151	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—MTHFR—glaucoma	6.04e-05	0.00148	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GSTT1—glaucoma	5.88e-05	0.00144	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CA5A—glaucoma	5.83e-05	0.00143	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NARFL—glaucoma	5.83e-05	0.00143	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GSTM1—glaucoma	5.81e-05	0.00142	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GSTM1—glaucoma	5.81e-05	0.00142	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—APOE—glaucoma	5.63e-05	0.00138	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CAV1—glaucoma	5.57e-05	0.00136	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CA1—glaucoma	5.41e-05	0.00132	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—TXN—glaucoma	5.26e-05	0.00129	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CTSA—glaucoma	5.24e-05	0.00128	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—MTHFR—glaucoma	5.14e-05	0.00126	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—MTHFR—glaucoma	5.14e-05	0.00126	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.08e-05	0.00124	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CA2—glaucoma	4.94e-05	0.00121	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.8e-05	0.00117	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—APOE—glaucoma	4.78e-05	0.00117	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—APOE—glaucoma	4.78e-05	0.00117	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC6A13—glaucoma	4.77e-05	0.00117	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.75e-05	0.00116	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.74e-05	0.00116	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CAV1—glaucoma	4.74e-05	0.00116	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CAV1—glaucoma	4.74e-05	0.00116	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CYP1B1—glaucoma	4.69e-05	0.00115	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ABCA1—glaucoma	4.69e-05	0.00115	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.59e-05	0.00112	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—TP53—glaucoma	4.5e-05	0.0011	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—NOS3—glaucoma	4.22e-05	0.00103	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTT1—glaucoma	4.08e-05	0.000997	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PTGS2—glaucoma	3.86e-05	0.000943	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GSTM1—glaucoma	3.75e-05	0.000917	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—NOS3—glaucoma	3.58e-05	0.000877	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—NOS3—glaucoma	3.58e-05	0.000877	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.49e-05	0.000853	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—TXN—glaucoma	3.48e-05	0.000852	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—MTHFR—glaucoma	3.31e-05	0.00081	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.29e-05	0.000804	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTGS2—glaucoma	3.28e-05	0.000802	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTGS2—glaucoma	3.28e-05	0.000802	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ABCA1—glaucoma	3.25e-05	0.000795	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP1B1—glaucoma	3.25e-05	0.000795	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—APOE—glaucoma	3.08e-05	0.000754	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CAV1—glaucoma	3.05e-05	0.000747	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CA1—glaucoma	2.85e-05	0.000696	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CTSA—glaucoma	2.76e-05	0.000674	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTT1—glaucoma	2.7e-05	0.000661	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CA2—glaucoma	2.6e-05	0.000637	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTM1—glaucoma	2.6e-05	0.000635	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.54e-05	0.000622	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.54e-05	0.000622	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—NOS3—glaucoma	2.31e-05	0.000565	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—MTHFR—glaucoma	2.3e-05	0.000562	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ABCA1—glaucoma	2.15e-05	0.000526	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP1B1—glaucoma	2.15e-05	0.000526	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—APOE—glaucoma	2.14e-05	0.000523	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CAV1—glaucoma	2.12e-05	0.000518	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTGS2—glaucoma	2.11e-05	0.000517	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—TXN—glaucoma	1.83e-05	0.000448	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTM1—glaucoma	1.72e-05	0.000421	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.67e-05	0.000409	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.66e-05	0.000405	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NOS3—glaucoma	1.6e-05	0.000392	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—MTHFR—glaucoma	1.52e-05	0.000372	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTGS2—glaucoma	1.46e-05	0.000358	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTT1—glaucoma	1.42e-05	0.000348	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—APOE—glaucoma	1.42e-05	0.000346	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CAV1—glaucoma	1.4e-05	0.000343	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.15e-05	0.00028	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ABCA1—glaucoma	1.13e-05	0.000277	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP1B1—glaucoma	1.13e-05	0.000277	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NOS3—glaucoma	1.06e-05	0.000259	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTGS2—glaucoma	9.7e-06	0.000237	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTM1—glaucoma	9.06e-06	0.000222	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—MTHFR—glaucoma	8e-06	0.000196	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—APOE—glaucoma	7.45e-06	0.000182	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CAV1—glaucoma	7.38e-06	0.000181	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NOS3—glaucoma	5.58e-06	0.000137	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTGS2—glaucoma	5.1e-06	0.000125	CbGpPWpGaD
